In this episode of #ExpertAnswers, Dr. Andrew Taylor from Xenotech answers questions from a recent webinar where he provides an overview of processes by which drugs are metabolized and talks about the importance of drug metabolism and drug-drug interaction studies.
To watch the webinar, click here.
Associated Webinar: Are In Vitro Metabolism and Drug-Drug Interaction Studies Critical for an Investigational New Drug Application?
Talking Real Science with Micaela Merrill
Micaela Merrill discusses her inspiration for science, as well as where she plans to take her career in the future. Her current project is a subset of a larger research story that seeks to understand the risk factors and comorbidities of PTSD in a metropolitan population of Black Americans.
#ExpertAnswers: Artur Fedorowoski on Cardiovascular Dysautonomia in Post-COVID-19
Artur Fedorowski explains CV dysautonomia as a specific sequalae of acute COVID-19 and guides the audience in the diagnostic work-up of PASC patients with suspected cardiovascular complications.
#ExpertAnswers: Licy Yanes Cardozo on Androgens in Cardiovascular Physiology
Licy Yanes Cardozo expands on her research exploring the role of androgens on cardiovascular physiology in cis and transgender patients.
COMPLi HBS Legislation Series: France
This webinar explores France's governance of human biological samples for research, focusing on acquisition, storage, import/export, and unique requirements in comparison to global standards.
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection and Management
Artur Fedorowski, MD, PhD, describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.
Are In Vitro Metabolism and Drug-Drug Interaction Studies Critical for an Investigational New Drug Application?
Andrew G. Taylor, PhD provides an overview of processes by which drugs are metabolized and discusses the importance of drug metabolism and drug-drug interaction studies.